Topic: Cancer
Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness. The company said an independent monitoring committee recommended stopping the study. It concluded that figitumumab in conjunction with Tarceva ...
Watson Pharmaceuticals Inc. said the Food and Drug Administration approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month doses. Trelstar is developed by Debiopharm Group of Switzerland and marketed by Watson. Watson plans to launch the six-month dose in ...
Colorectal cancer or large bowl cancer is the cancer in the colon, rectum and appendix.
These are abnormal growth of polyps that later develop cancerous.
The diagnosis is done through colonoscopy. The treatment is done by the surgery followed by chemotherapy.
Factors contributing towards colorectal cancer
Age: People in the age of 60s ? 70s have higher chances of developing this ...
WASHINGTON (Reuters) - The most commonly used tool for detecting prostate cancer, routine PSA screening, has become "a hugely expensive public health disaster," its discoverer said on Wednesday. Dr. Richard Ablin of the University of Arizona joined the ongoing debate over the blood test, saying the screening procedure is too costly and ineffective. "I never dreamed that my discovery four decades ...
